Background/Aims: The aim of our study was to investigate the effect of high-salt diet on the renal expression of renalase and the potential role of the local renin-angiotensin system in this process. Methods: Sprague-Dawley (SD) rats were divided into groups according to salt content in diet and drug treatment as follows: normal-salt diet (NS), high-salt diet (HS), highsalt intake with hydralazine (HS+H), high-salt diet with enalapril (HS+E), and high-salt diet with valsartan (HS+V). The dietary intervention and drugs were given for four weeks. Renin activity and angiotensin II type 1 receptor (AT1R) levels were detected by real-time PCR. Renalase mRNA and protein were also measured. Results: After four weeks, systolic blood pressure and proteinuria were significantly increased in the HS group with respect to the NS group. Dietary salt intake caused a dramatic decrease in renalase expression in the rat kidneys. Renal cortex renin and AT1R increased significantly in the HS and HS+H groups. Urinary protein was positively correlated with renal renin and AT1R levels. However, in the HS+E and HS+V groups, enalapril and valsartan failed to influence renal renalase expression but abolished the increase in proteinuria, renal cortex renin, and AT1R levels with respect to the HS group. Conclusion: This study indicates that high salt intake reduces renal expression, and renal RAS may be not involved in the regulation of renalase in SD rats fed with high-salt diet.
Introduction
Renalase, first discovered in 2005, is a flavin-adenine-dinucleotide-dependent amine oxidase that is secreted into the blood by the kidneys and is hypothesized to participate in catecholamine metabolism [1] . Several cells can synthesize and secrete renalase, but renal proximal tubules are the major sites from which renalase originates [2, 3] . Previous evidence revealed that recombinant renalase exerts powerful and rapid hypotensive effects on rats; this effect was suggested to be mediated by the degradation of circulating catecholamines, which could decrease cardiac contractility and heart rate [4, 5] . Whether renalase is an amine oxidase or not is presently debated. Aliverti and Moran et al. [6] [7] [8] failed to demonstrate the catalytic activity of renalase, which is contradictory to the investigation reported by Xu et al. [1] . Thus, additional evidence is needed to confirm whether renalase is an amine oxidase. Renalase deficiency has been reportedly associated with chronic kidney disease, heart disease, diabetes, stroke, and hypertension [9] [10] [11] [12] .
Excess dietary salt is strongly correlated with cardiovascular disease, morbidity, and mortality; it is considered to be a major contributing factor to the pathogenesis of hypertension [13, 14] . Recent findings have shown that high dietary salt decreases blood and kidney renalase levels in rats subjected to subtotal nephrectomy as well as in Dahl saltsensitive rats [15] . These results were demonstrated by our recent studies, in which we found that high-salt diet causes a significant decrease in serum renalase levels and increase in urinary renalase secretion in Chinese adults [16, 17] . In addition, we recently showed that polymorphisms of the renalase gene were associated with blood-pressure (BP) responses to dietary salt intake in a family-based study [18] . However, the relationship between salt intake and renalase expression has not been fully established and deserves further investigation.
The renin-angiotensin system (RAS) is the circulating endocrine system that regulates blood-pressure and electrolyte homeostasis. In addition to the classical systemic RAS, local tissue-specific RASs have also been identified in various organs. The renal RAS was identified and believed to be potentially associated with the regulation of renalase. RAS inhibitors were shown to upregulate renal-tissue and circulating renalase levels in rats with adriamycininduced nephropathy and mice with high-fat intake [19, 20] . Whether local RAS affects renal renalase expression under the high-salt condition is not understood. We hypothesized that the renal RAS may be involved in the regulation of renalase in the kidney. Therefore, in this study, we preliminarily explored the possible role of renal RAS in the regulation of renalase by examining the renal renalase expression in Sprague-Dawley (SD) rats fed with a high-salt diet and the effects of enalapril and valsartan on renalase expression.
Materials and Methods

Animals
Seven-week-old male SD rats from the Animal Center of the Medical School of Xi'an Jiaotong University were housed in individual cages under controlled light (12 h/12 h dark/light cycle) and temperature (20-23 °C) conditions. All the rats were allowed to consume standard diet and tap water. The study was carried out in strict accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health.
Experimental design
The rats were randomly divided into five groups according to the salt content in the diet and drug treatment as follows: normal salt diet (NS, 0.3% NaCl), high-salt diet (HS, 8% NaCl), high-salt diet with 20 mg/kg/day of hydralazine (HS+H group; Genshare Biological, Shaanxi, China), high-salt diet with 10 mg/kg/day of enalapril (HS+E group; Cisen Pharmaceutical Co., Ltd, Shandong, China), and high-salt diet Table 1 . Primers used in Real-time PCR experiments neally for anesthesia. Blood samples were collected from the abdominal aorta to isolate the serum and plasma and then stored at −80 °C until analysis. The left kidney was also harvested for study. The right kidney was fixed in 10% formalin for immunohistochemical examination. The experimental protocols were approved by the Institutional Animal Ethics Committee of Xi'an Jiaotong University.
Physiological and biochemical measurements
The systolic BP (SBP) of the rats was measured through a noninvasive tail-cuff method using the BP-2000 blood-pressure-analysis system (Visitech Systems, USA). All rats performed adaptive training adjusted to blood-pressure measurements by tail-cuff plethysmography prior to the final measurements. A cuff was placed around the tail of each rat and inflated to 240 mmHg. The pressure at which the first tail pulse was detected was recorded as the SBP. SBP was measured 10 times, and the average value was calculated. Serum Na/K, serum creatinine, 24 h urinary protein, and 24 h urinary Na/K were analyzed using a Hitachi 7060 automatic biochemical analyzer (Hitachi, Ltd., Japan). Plasma renalase levels were measured using a commercially available enzyme-linked immunosorbent assay kit (Uscn Life Science, Inc., Wuhan, China).
Immunohistochemistry
Immunohistochemistry was conducted as previously reported [21] . Briefly, serial 5 μm paraffinembedded tissue sections were dewaxed and rehydrated. Endogenous peroxidase activity was inhibited by incubating the sections in 3.0% hydrogen peroxide. The sections were incubated overnight at 4 °C with renalase (Abcam, USA 1:100) antibody and an appropriate secondary antibody at room temperature for 30 min. The sections were photographed through an upright fluorescence microscopic imaging system (BX51 Olympus, Japan). To evaluate the immunoperoxidase stain of renalase, 10 non-overlapping fields at 20× magnification were randomly selected from each kidney section. The immunoperoxidase stain was quantified using the Image Pro Plus 6.0 imaging software (Media Cybernetics, USA). Data were reported as the mean optical density in each field area.
Quantitative real-time PCR
Total RNA from the kidney tissues was isolated using TRIzol reagent (Takara Bio, Japan). The mRNA expression levels were quantified from the total RNA using real-time PCR with SYBR Premix Ex Taq™ II (Takara Bio, Japan). GAPDH was used as an internal control for the mRNAs. The primers employed in this study are shown in Table 1 . The protocol for RT-PCR was based on our previous method [21] . The mRNA expression values are shown in folds of mRNA expression in the tissues of SD rats fed with normal salt diet.
Western blot analysis
The renal tissues were homogenized and lysed with RIPA lysis buffer (Genshare, Shaanxi, China). The supernatant was collected after centrifugation at 14,000 rpm for 15 min at 4 °C. The proteins were then quantified by the Bradford assay with a protein assay kit. Portions of protein (30 μg) per sample were separated through a 10% sodium dodecyl sulfate-polyacrylamide gel and transferred to nitrocellulose membranes at 30 V for 1.5 h. Non-specific binding was blocked with 5% skim milk for 2 h at room temperature. Subsequently, the membrane was blocked with 5% skimmed milk in 0.1% Tris-buffered saline-Tween (TBST) and then probed with antibodies directed against renalase (1:3000; Abcam, Cambridge, UK) or GAPDH (1:1000, with 40 mg/kg/day of valsartan (HS+V group; Novartis Inc., Basel, Switzerland). Each group comprised six rats. The treatments were administered daily by gavage. Four rats in each treatment group were placed in metabolic cages for 24 h urine collection before experiment termination. After four weeks, the rats were given 10% chloral hydrate injection intraperito-ware SPSS version 16.0 (Chicago, IL, USA) was used for data analysis. All the data were expressed as mean ± standard error of the mean. One-way ANOVA and the Kruskal-Wallis test were used for parametric and non-parametric data comparisons, respectively. Correlations were evaluated by the Pearson correlation analysis. A value of P < 0.05 was considered significant.
Result
General data of laboratory animals
All rats exhibited normal physiologic activities and were healthy during the dietary intervention. At baseline, no significant differences in SBP were detected among groups. After four weeks of high-salt diet, the SBP of the HS group increased significantly, but was dramatically decreased by enalapril, valsartan, and hydralazine (P < 0.05, Fig. 1) . Moreover, the 24 h urinary Na/K and urinary protein increased sharply in the HS group, but proteinuria was significantly reduced by enalapril and valsartan (P < 0.05, Table 2 ).
mRNA expression in the kidney RAS
To demonstrate the effects of the dietary and drug interventions on renal RAS, we investigated the mRNA expression of renin and AT1R in the renal cortex of the rats in each group. The mRNA expression of renin and AT1R increased significantly in the HS group (P < 0.05), remained stable in the HS+H group, but was restored by enalapril and valsartan (P < 0.05; Fig. 2 ).
In addition, the urinary protein excretions correlated positively with the renal cortex mRNA expression of renin (r = 0.864, P < 0.001) and AT1R (r = 0.51, P = 0.022) in all groups.
Plasma renalase levels and expression in kidney tissues
Plasma renalase content was dramatically decreased after salt loading when compared with the NS group (P < 0.05, Table 2 ) and remained unchanged with respect to the other three groups. Compared with those in the NS group, the renalase protein expression in the HS group decreased markedly (P < 0.05). By contrast, renalase protein expression in the HS+H group did not differ from those in the HS group and were not influenced by treatment with either enalapril or valsartan (P > 0.05, Fig. 3A ). As shown in Fig. 3B , renalase mRNA expression also exhibited the same trends among the different groups. Cell Signaling Technology, Beverly, MA, USA) at 4 °C overnight, followed by washing thrice in TBST. The membrane was then incubated with horseradish-peroxidase-conjugated anti-rabbit (1:10,000; Thermo Scientific, USA) IgG for 2 h at room temperature. All the data were obtained from ChemiDoc XRS+ System (Bio-Rad, Hercules, CA, USA) and band intensities were analyzed using Quality One software.
Statistical Analysis
The statistical soft-We also examined the renalase protein expression levels and locations in the rat renal cortices by immunohistochemistry analysis. Renalase was strongly expressed in the renal tubules and scattered in the glomeruli of the NS group (Fig. 4) . In the HS renal tissue, the intensity and number of renalasepositive cells decreased. Quantification of renalasepositive areas in the kidneys, as summarized in Fig. 4A , indicated a significantly lower expression of renalase in the HS group than in the NS group (P < 0.01). In addition, renalase expression was not increased by enalapril and valsartan in the treatment groups (Fig. 4) .
Discussion
The results of the present study demonstrated that increased dietary sodium intake downregulates renal tissues and plasma renalase levels and significantly increases the expression of the key elements of the local RAS (renin and AT1R) in the kidney. Furthermore, the study showed that RAS inhibitors (enalapril and valsartan) could not alter the renal expression of renalase in SD rats given high-salt diet.
To date, a limited number of studies have shown the association between decreased renalase production and high sodium intake. Ghosh et al. [22] discovered that in Dahl saltsensitive rats fed with an 8% sodium chloride diet for three weeks, blood and kidney tissue renalase levels were significantly decreased. Quelhas-Santos et al. [23] reported that high salt intake markedly accentuated the decrease in blood and renal tissue renalase levels in rats that underwent 3/4 nephrectomy. More recently, in our study of dietary intervention, we found that low salt intake significantly increased serum renalase levels from the baseline, and high salt intake decreased serum renalase levels from those of low salt intake [16] . We further showed that dietary salt intake dramatically increases urinary renalase excretions in the Chinese cohort [17] . This observation was unexpected mainly because high levels of dietary salt are believed to potentially reduce blood and kidney renalase levels. However, the changes in urinary renalase levels appear to be unaccounted by the changes in either renal-tissue or circulating renalase levels. Furthermore, the source of urine renalase is not fully documented. Our family-based association study identified several single-nucleotide polymorphisms of the renalase gene, namely, rs919115, rs792205, and rs12356177, which were associated with BP responses to changes in dietary salt intake [18] . In a study by Fedchenko et al. [24] that involved SHR, the kidney renalase mRNA in rats with a moderate increase in BP (140 mm Hg) did not change as much as that in the control rats. In the current study, we observed pronounced decreases in renal and circulating renalase levels in the HS and HS+H groups, which indicated that high salt intake, independent of BP, decreased the renalase expression in the SD rats. Although the mechanism by which excessive salt inhibits renalase is unknown, recent observations point to an important role for RAS.
In traditional theory, the normal response to increased salt intake is the suppression of the circulating RAS. However, recent studies suggest that renal RAS action varies independently or conversely with the plasma RAS in high salt intake, and the inappropriate activation of the intrarenal RAS may contribute directly to hypertension and renal damage. In Dahl salt-sensitive (DS) rats, Kobori et al. [25] showed that plasma renin activity and angiotensinogen (AGT) levels decreased but intrarenal AGT increased after high salt intake. This observation was also confirmed by Chandramohan et al., who suggested that high-salt diet lowers plasma renin activity but increases the number of kidney angiotensin II (Ang II)-positive cells and Ang II type 1 receptor (AT1R) in DS rats [26] . In a recent study, Wu et al. [27] reported that hypertension induced by high salt levels and renal damage causes the upregulation of renal cortex renin, AGT, and Ang II; in addition, the blockage of AT1R decreased the proteinuria in Wistar rats. These observations are consistent with the results of our study, in which high salt intake increased the mRNA expression of RAS components in the renal cortex, and the blockage of the angiotensin converting enzyme (ACE) and AT1R decreased the proteinuria. Previous studies also demonstrated that elevated Ang II not only induces hypertension but also elicits inflammatory and immunological responses that contribute to interstitial fibrosis, glomerulosclerosis, albuminuria, and finally, renal failure [28] . In the current study, the intrarenal RAS was inappropriately enhanced by high salt intake in the SD rats and associated with increased urinary protein excretions.
Experimental data provided evidence that the intrarenal RAS may be closely associated with renal expression induced by high salt. Han et al. [19] were the first to demonstrate that the ACE inhibitor lisinopril markedly increased the expression of renalase in the kidney tissues of rats with adriamycin-induced nephropathy. More recently, Zhou et al. [20] discovered that valsartan, an AT1R antagonist, promoted the stabilization of atherosclerotic plaque by increasing serum renalase and renalase expression in the fibrous cap of the atherosclerotic plaques in ApoE −/− mice fed with high-fat diet. Therefore, a high-salt load may reduce the expression of renalase in kidney secondary to activation of the renal RAS. Our results showed that blocking the action of the intrarenal RAS with either valsartan or enalapril did not significantly change the renal expression of renalase in rats treated with a high-salt diet. This finding may suggest that the inappropriate activation of intrarenal RAS may not contribute directly to the decreased renalase expression in rats that received highsalt diet. Although the mechanism(s) by which increased salt downregulates the expression of renalase in the kidney remains to be determined, experimental evidence has pointed to the importance of the intrarenal sympathetic nervous system in this process. High salt intake stimulates the sympathetic nervous system and facilitates catecholamine secretion and expression in the kidney [29, 30] . Therefore, sympathetic activation may decrease the renal renalase expression as reported by Jiang et al. [31] In their study of spontaneously hypertensive rats, renal denervation lowered BP and upregulated the plasma renalase concentration and expression level in the kidney. However, we cannot exclude the possibility that other factors may participate in this process, which entails further investigation.
Conclusion
The present study demonstrated that high salt intake markedly reduced renalase expression and upregulated the local RAS processes in SD rat kidneys. Our results also suggested that the blockage of ACE or AT1R has no significant impact on the renal renalase expression in SD rats with high-salt diet. These findings may contribute to a better understanding of the roles of salt and RAS inhibitors in BP regulation and may provide potential clinical and public health implications.
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